TWD 21.75
(1.4%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 481.48 Million TWD | -9.93% |
2022 | 534.57 Million TWD | -10.25% |
2021 | 595.65 Million TWD | 3.14% |
2020 | 577.5 Million TWD | 23.89% |
2019 | 466.14 Million TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 448.52 Million TWD | -6.85% |
2024 Q2 | 448.52 Million TWD | 0.0% |
2023 Q3 | 481.48 Million TWD | -6.3% |
2023 FY | 481.48 Million TWD | -9.93% |
2023 Q4 | 481.48 Million TWD | 0.0% |
2023 Q2 | 513.84 Million TWD | 0.0% |
2023 Q1 | 513.84 Million TWD | -3.88% |
2022 Q4 | 534.57 Million TWD | 0.0% |
2022 FY | 534.57 Million TWD | -10.25% |
2022 Q3 | 534.57 Million TWD | 0.0% |
2021 FY | 595.65 Million TWD | 3.14% |
2020 FY | 577.5 Million TWD | 23.89% |
2019 FY | - TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 17.48% |
Level Biotechnology Inc. | 273.2 Million TWD | -76.239% |
Sagittarius Life Science Corp | 137.82 Million TWD | -249.349% |
NeoCore Technology Co., Ltd. | 197.47 Million TWD | -143.827% |
TaiMed Biologics Inc. | 1.32 Billion TWD | 63.739% |
GlycoNex Incorporation | 276.39 Million TWD | -74.2% |
VBI | 21.25 Million TWD | -2165.715% |
GeneReach Biotechnology Corp. | 313.7 Million TWD | -53.484% |
Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 6.444% |
Visgeneer Inc. | 185.6 Million TWD | -159.415% |
Mycenax Biotech Inc. | 1.32 Billion TWD | 63.612% |
Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 34.312% |
G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -301.708% |
Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 78.563% |
TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -7175.416% |
Enimmune corporation | 173.46 Million TWD | -177.573% |
TaiRx, Inc. | 60.62 Million TWD | -694.205% |
CHO Pharma, Inc. | 110.83 Million TWD | -334.43% |
EirGenix Inc. | 1.14 Billion TWD | 57.952% |
BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -329.972% |
Sunny Pharmtech Inc. | 512.43 Million TWD | 6.04% |
Lin BioScience, Inc. | 167.73 Million TWD | -187.061% |
BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -413.783% |
Feng Chi Biotech Corp. | 63.03 Million TWD | -663.853% |
Bio Preventive Medicine Corp. | 124.72 Million TWD | -286.027% |
Lukas Biomedical Inc. | 161.05 Million TWD | -198.951% |
RBC Bioscience Corporation | 513.08 Million TWD | 6.158% |
BiOptic Inc. | 170.56 Million TWD | -182.293% |
BRIM Biotechnology, Inc. | 42.15 Million TWD | -1042.101% |
Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -1970.467% |
Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -1695.722% |
Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 50.598% |
Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -6784.287% |
SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -2168.383% |
Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | -30.721% |
Neith Corporation | 17.43 Million TWD | -2661.929% |
Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -5939.727% |
NaviFUS Corp. | 53.4 Million TWD | -801.644% |
Sinew Pharma Inc. | 39.71 Million TWD | -1112.386% |
Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -729.592% |
Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | -32.104% |
Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | -111.462% |
AP Biosciences Inc | 106.65 Million TWD | -351.465% |
Medigen Biotechnology Corp. | 3.53 Billion TWD | 86.361% |
3D Global Biotech Inc. | 30.68 Million TWD | -1469.333% |
Pharmosa Biopharm Inc. | 195.99 Million TWD | -145.669% |
Intech Biopharm Corporation | 1.54 Billion TWD | 68.8% |
Oneness Biotech Co., Ltd. | 866.42 Million TWD | 44.429% |
Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -5090.675% |
TWi Biotechnology, Inc. | 55.81 Million TWD | -762.679% |
Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | -106.683% |
TCI GENE Inc. | 155.54 Million TWD | -209.542% |
MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -1787.592% |
Senhwa Biosciences, Inc. | 46.17 Million TWD | -942.744% |
Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | -46.585% |
NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -642.039% |
PharmaEngine, Inc. | 91 Million TWD | -429.072% |
Savior Lifetec Corporation | 457.95 Million TWD | -5.138% |
TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -334.007% |
OBI Pharma, Inc. | 650.44 Million TWD | 25.976% |
Meribank Biotech Co., Ltd | 390.81 Million TWD | -23.202% |
Acepodia, Inc. | 384.47 Million TWD | -25.233% |
Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -462.794% |